BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Mauna Kea Technologies Announces the Publication of a Study Confirming the Value of the Cellvizio® System in Colorectal Cancer Follow-Up

  December 13, 2011

   · 

  5 min read
• Drug Development

  Top-Line Phase 2 Data Indicate Repros Therapeutics Inc.'s Androxal(R) Normalizes Testicular Function in Men With Type 2 Diabetes

  December 13, 2011

   · 

  5 min read
• Drug Development

  Celgene Corporation Release: Phase II Study Evaluates Clinical Benefit of Pomalidomide in Heavily Pre-Treated Patients with Multiple Myeloma

  December 13, 2011

   · 

  1 min read
• ChinaBio Today Release: China Will Regulate TCMs to Improve Their Purity

  December 13, 2011

   · 

  1 min read
• Genetown

  Alnylam Pharmaceuticals Scientists Present New Data on RNAi Therapeutics at 53rd American Society of Hematology Annual Meeting

  December 13, 2011

   · 

  1 min read
• Drug Development

  Bio-Path Holdings, Inc.’s Initial Phase I Data in Leukemia Clinical Trial Demonstrates That its Neutral Lipid Delivery Technology Antisense Drug BP-100-1.01 (Liposomal Grb-2) is Well Tolerated with Activity Seen at Low Starting Dose

  December 13, 2011

   · 

  1 min read
• Business

  Liquidia Technologies Inc. Announces Collaboration with PATH to Develop Next Generation Pneumococcal Vaccine

  December 13, 2011

   · 

  1 min read
• Drug Development

  Progress of GlycoMimetics, Inc.’s Novel Compounds Highlighted at 2011 Annual Meeting of the American Society of Hematology

  December 13, 2011

   · 

  1 min read
• Drug Development

  Biovest International, Inc. Release: BiovaxID® Lymphoma Vaccine-Induced T-Cell Immune Responses Complement Rituximab Induction Chemotherapy and Significantly Correlate with Overall Survival in Mantle Cell Lymphoma

  December 13, 2011

   · 

  1 min read
• Drug Development

  Biovest International, Inc. Release: BiovaxID® Lymphoma Vaccine-Induced T-Cell Immune Responses Complement Rituximab Induction Chemotherapy and Significantly Correlate with Overall Survival in Mantle Cell Lymphoma

  December 13, 2011

   · 

  1 min read